A subunit of coatomer protein complex offers a novel tumor-specific target through a surprising mechanism

Area of Science:

• Cell Biology
• Cancer Research
• Molecular Medicine

Background:

• Coatomer protein complex I (COPI) is crucial for intracellular transport between the Golgi and endoplasmic reticulum.
• COPI dysfunction leads to Golgi fragmentation, impaired autophagy, and cell death.
• COPI is essential for all cell types, seemingly precluding its use as a cancer therapy target.

Purpose of the Study:

• To identify novel, cancer-specific therapeutic targets.
• To investigate the potential of COPI subunits as anti-cancer agents.
• To elucidate the mechanism of tumor selectivity for a novel cancer target.

Main Methods:

• Function-based genomic screening to identify cancer-specific vulnerabilities.
• Depletion of specific COPI subunits in cancer cell models.
• Assessment of cell viability in both proliferating and growth-arrested tumor cells and normal cells.

Main Results:

• A specific COPI subunit, zeta 1 (ζ1), was identified as a cancer-specific target.
• Depletion of ζ1 induced cell death in both dividing and non-dividing tumor cells.
• Normal cells remained unaffected by ζ1 depletion, demonstrating tumor selectivity.

Conclusions:

• The COPI subunit ζ1 represents a novel and highly selective cancer therapeutic target.
• Targeting ζ1 offers a promising strategy for cancer treatment, effective against both proliferating and non-proliferating tumor cells.
• The mechanism underlying ζ1's tumor selectivity is unprecedented and warrants further investigation.